Home » PLATINUM China Trial Demonstrates Positive Outcomes for the Boston Scientific PROMUS Element Stent

PLATINUM China Trial Demonstrates Positive Outcomes for the Boston Scientific PROMUS Element Stent

March 22, 2013

Boston Scientific Corporation reported clinical endpoint data from the PLATINUM China clinical trial evaluating the safety and effectiveness of the PROMUS Element Everolimus-Eluting Platinum Chromium Coronary Stent System.
Boston Scientific

04Apr
Optimizing Quality Control Operations with Unified Quality
20Apr
Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC
25Apr
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
26Apr
FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know
27Apr
Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis
17May
2023 WCG Avoca Quality Consortium Summit

PLATINUM China Trial Demonstrates Positive Outcomes for the Boston Scientific PROMUS Element Stent

Upcoming Events

Optimizing Quality Control Operations with Unified Quality

Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

2023 WCG Avoca Quality Consortium Summit

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

FDA Deems Cardiosave Intra-Aortic Balloon Recall Class I

Xtandi Shows Promise in Prostate Cancer Trial

Implantable Sleeve that Holds Spinal Screws in Place Gets FDA Clearance

FDA Green Lights Clinical Trial of Low-Dose Psilocybin

The Revised ICH E8: A Guide to New Clinical Trial Requirements